SEC Form 4Coverage since Jun 9, 2026
$ABOS insider trading
Over the last 12 months, Acumen Pharmaceuticals insiders reported no purchases and 2 sales totaling $90K across SEC Form 4 filings.
- Bought · 12m
- — 0 events
- Sold · 12m
- $90K 2 events
- Events · 12m
- 2 Form 4 filings, grouped
- Insiders · 12m
- 2 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $ABOS · 12Mvia TradingView
Top insiders · 12m
Fountain Nathan B—1× · $14K
Porter Derrell—1× · $75K
All insider trades
2 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | Porter DerrellD | ▼ Sale | 32,300 | $2.33 | $75K | -47.6% | 3 tranches |
| Jun 9, 2026 | Fountain Nathan BD | ▼ Sale | 6,400 | $2.23 | $14K | -11.7% | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $ABOS feed.